| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 5/6 |
CompuGroup Medical SE & Co. KGaA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €13.82 |
| 52 Week High | €40.84 |
| 52 Week Low | €13.10 |
| Beta | 0.88 |
| 11 Month Change | -2.81% |
| 3 Month Change | -12.53% |
| 1 Year Change | -60.26% |
| 33 Year Change | -81.66% |
| 5 Year Change | -75.71% |
| Change since IPO | 71.29% |
Recent News & Updates
Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Sep 06
Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden
Aug 20What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash
Aug 04CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price
Jul 18Recent updates
Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Sep 06Here's Why CompuGroup Medical SE KGaA (ETR:COP) Has A Meaningful Debt Burden
Aug 20What You Can Learn From CompuGroup Medical SE & Co. KGaA's (ETR:COP) P/E After Its 34% Share Price Crash
Aug 04CompuGroup Medical SE & Co. KGaA (ETR:COP) Just Reported Earnings, And Analysts Cut Their Target Price
Jul 18Is It Too Late To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jul 15Investors Still Waiting For A Pull Back In CompuGroup Medical SE & Co. KGaA (ETR:COP)
Jun 11The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
May 24Earnings Release: Here's Why Analysts Cut Their CompuGroup Medical SE & Co. KGaA (ETR:COP) Price Target To €43.20
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00
Apr 27CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Mar 20CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate
Feb 08Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings
Jan 25Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jan 12The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Dec 28We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Dec 15Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?
Oct 09CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital
Sep 22Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?
Sep 07Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?
Aug 23Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly
Jul 13At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?
Jun 24CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return
May 27CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?
May 06We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Apr 06What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Mar 07Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital
Feb 06An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued
Jan 21These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well
Jan 05Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Dec 06CompuGroup Medical SE KGaA (ETR:COP) May Have Issues Allocating Its Capital
Oct 27Are Investors Undervaluing CompuGroup Medical SE & Co. KGaA (ETR:COP) By 49%?
Oct 12At €39.20, Is It Time To Put CompuGroup Medical SE & Co. KGaA (ETR:COP) On Your Watch List?
Sep 04CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Aug 04Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Jul 16When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?
May 31CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Shareholder Returns
| COP | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 1.1% | -2.2% | -1.0% |
| 1Y | -60.3% | -38.9% | 16.1% |
Return vs Industry: COP underperformed the German Healthcare Services industry which returned -36.9% over the past year.
Return vs Market: COP underperformed the German Market which returned 18.1% over the past year.
Price Volatility
| COP volatility | |
|---|---|
| COP Average Weekly Movement | 4.2% |
| Healthcare Services Industry Average Movement | 5.3% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: COP has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: COP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 8,424 | Daniel Gotthardt | www.cgm.com |
CompuGroup Medical SE & Co. KGaA provides e-health services worldwide. It operates through Ambulatory Information Systems, Hospital Information Systems, Consumer and Health Management Information Systems, and Pharmacy Information Systems segments. The Ambulatory Information Systems segment develops and sells practice management software for registered physicians, medical care centers, and physician networks; offers supplementary app, internet, and intranet solutions; and delivers solutions for medical facilities, such as medica; care centers and practice associations.
CompuGroup Medical SE & Co. KGaA Fundamentals Summary
| COP fundamental statistics | |
|---|---|
| Market cap | €714.98m |
| Earnings (TTM) | €32.49m |
| Revenue (TTM) | €1.19b |
22.0x
P/E Ratio0.6x
P/S RatioIs COP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COP income statement (TTM) | |
|---|---|
| Revenue | €1.19b |
| Cost of Revenue | €808.62m |
| Gross Profit | €384.17m |
| Other Expenses | €351.67m |
| Earnings | €32.49m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | 0.63 |
| Gross Margin | 32.21% |
| Net Profit Margin | 2.72% |
| Debt/Equity Ratio | 124.4% |
How did COP perform over the long term?
See historical performance and comparison